Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Are Spin-Outs Really a Better Bet?

Oct 01 2004

• By Melanie Senior

Related Content

Actelion: A Model for European Biotech

Sep 01 2003

Europe's Flavors of Sustainable BioPharma

Sep 01 2004

Bayer: Out of Trouble Come Opportunities

Oct 01 2004

Related Companies

AstraZeneca PLC

Sanofi

Bayer AG

Aerovance, Inc.

Roche Holding AG

Basilea Pharmaceutica Ltd.

Swedish Orphan Biovitrum AB

Amgen, Inc.

Actelion Pharmaceuticals Ltd.

Novo Nordisk A/S

ZymoGenetics

Genentech, Inc.

Johnson & Johnson

Barrier Therapeutics

Viatris Inc.

Alfasigma S.p.A.

GSK plc

Affymax, Inc.

NeuroSearch A/S

Gloriana Therapeutics, Inc.

Sophion Bioscience AS

Additional Topics

Strategy Business Strategies BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window